Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Pharma-Bio Serv (PBSV) over the last 11 years, with Q4 2025 value amounting to $7.5 million.

  • Pharma-Bio Serv's Short-term Investments rose 2504.6% to $7.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $7.5 million, marking a year-over-year increase of 2504.6%. This contributed to the annual value of $7.5 million for FY2025, which is 2504.6% up from last year.
  • Pharma-Bio Serv's Short-term Investments amounted to $7.5 million in Q4 2025, which was up 2504.6% from $6.8 million recorded in Q3 2025.
  • In the past 5 years, Pharma-Bio Serv's Short-term Investments registered a high of $11.7 million during Q3 2023, and its lowest value of $4.5 million during Q4 2023.
  • Over the past 3 years, Pharma-Bio Serv's median Short-term Investments value was $7.1 million (recorded in 2025), while the average stood at $7.5 million.
  • In the last 5 years, Pharma-Bio Serv's Short-term Investments soared by 8097.96% in 2024 and then tumbled by 4588.91% in 2025.
  • Pharma-Bio Serv's Short-term Investments (Quarter) stood at $4.5 million in 2023, then soared by 31.93% to $6.0 million in 2024, then grew by 25.05% to $7.5 million in 2025.
  • Its Short-term Investments stands at $7.5 million for Q4 2025, versus $6.8 million for Q3 2025 and $8.3 million for Q2 2025.